|
||
by From Pink to Prevention From Pink to Prevention is a new initiative formed in 2013 by Deborah Burton from Tipping Point North South, Helen Lynn from the Alliance for Cancer Prevention, and Diana Ward of the Working Group on Primary Prevention of Breast Cancer. The group grew out of an ongoing struggle to . . . → Read More: Press Release: Open letter to Breakthrough (Breast Cancer Now) 
“DDT Exposure During Pregnancy Linked To Breast Cancer,” by Justin Worland, Time. DDT (dichlorodiphenyltrichloroethane), previously linked to Alzheimer’s disease, obesity, and kidney and ovarian diseases, was taken out of use 30 years ago because of its harmful effects on health and the environment. A study published in the Journal of Clinical Endocrinology & Metabolism shows . . . → Read More: DDT Exposure During Pregnancy Linked To Breast Cancer
“Screening for breast cancer? That will be $1,500,” by Beth Wolfensberger Singer, The Boston Globe. Graphic arts engage readers in a way that text cannot. Told with a sequences of pictures, along with narration and dialogue (often in the form of speech bubbles), graphic arts have become increasingly popular media for education and communication . . . → Read More: Screening for breast cancer? That will be $1,500
“Why did last week’s mammography study get so much news, but the DCIS study didn’t?” by Gary Schwitzer, Health News Review. Health News Review editor Gary Schwitzer argues that journalists were handed a wonderful opportunity to educate readers about one important part of the dilemma in breast cancer screening recommendations, but most of them blew . . . → Read More: Why did the mammography study get so much news, but the DCIS study didn’t? 
Dear Friends, I hope this issue of the BCCQ finds you well. Spring has been eventful, insightful, inspiring, and also sad. We honor the life of Lisa Bonchek Adams, a smart, eloquent blogger who was committed to evidence-based medicine and sharing aspects of breast cancer that remain hidden beneath fundraising campaigns and awareness events. . . . → Read More: BCCQ (2015, Issue 2) is Out! 
A recent article in The New York Times “New Genetic Tests for Breast Cancer Hold Promise” describes new and cheaper tests for BRCA1 and 2 gene mutations that carry added risk for breast and ovarian cancers. Medical guidelines generally limit testing of the so-called “breast cancer genes” to the small percentage of people who already . . . → Read More: Surge in competition in genetic risk screening warrants caution
“Pharmascolds Are Not Worse Than The Pervasive Conflicts Of Interest They Criticize,” by Larry Huston, Forbes. Let’s start with a quick poll: Which is worse? A. The pervasive influence of industry on medicine, which has undermined the independence and altruism of physicians. B. The critics of industry influence, who have created a paranoid culture . . . → Read More: Pharmascolds are not worse than the pervasive conflicts of interest, they criticize 
By Beth Fairchild www.metavivor.org The METAvivor non-profit was established in 2009 by a small group pro-active metastatic breast cancer patients who felt that the lack of research and support dedicated to their disease and to those suffering from it was just plain wrong. This year, the group planned Sea to Sea for MBC, . . . → Read More: Sea to Sea for MBC: Getting to Know the REAL CJ |
||
| Copyright © 2025 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||